Skip to content
ppharmaranks
Menu

beta3-Adrenergic Agonist drugs compared

Compare all 2 beta3-Adrenergic Agonist drugs side by side, used for conditions such as urinary bladder, overactive, urinary incontinence, urge. They share one FDA-defined mechanism but differ in approved uses, prescription status, brand-vs-generic options, price, and FDA recall-safety record — which our independent rating scores.

Full ranking · 2 drugs

  1. 1

    myrbetriq

    Mirabegron

    New
  2. 2

    myrbetriq granules

    Mirabegron

    New

Frequently asked questions

What is the beta3-Adrenergic Agonist drug class?

beta3-Adrenergic Agonist is an FDA Established Pharmacologic Class (EPC) — a group of drugs that share a mechanism of action. pharmaranks lists 2 beta3-Adrenergic Agonist products, each independently rated.

Are all beta3-Adrenergic Agonist drugs the same?

No. beta3-Adrenergic Agonist drugs share the same core mechanism — that is why they sit in one FDA class — but they differ in their approved uses, available forms, whether they are prescription or over-the-counter, brand-vs-generic options and price, and their FDA recall-safety record.

What conditions do beta3-Adrenergic Agonist drugs treat?

Per NIH RxClass drug-classification data, beta3-Adrenergic Agonist drugs are used for conditions including urinary bladder, overactive, urinary incontinence, urge.

Sources: the beta3-Adrenergic Agonist class definition and its member drugs come from the U.S. NLM RxClass (Established Pharmacologic Class). Ratings are pharmaranks’ independent FDA recall-safety analysis.